Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport

References

1 Wallace JD, Cuneo RC, Baxter R, Orskov H, Keay N, Pentecost C, et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab 1999; 84: 3591–601. Search in Google Scholar

2 Wallace JD, Cuneo RC, Lundberg PA, Rosen T, Jorgensen JO, Longobardi S, et al. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 2000; 85: 124–33. Search in Google Scholar

3 Longobardi S, Keay N, Ehrnborg C, Cittadini A, Dall R, Boroujerdi MA, et al. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab 2000; 85: 1505–12. Search in Google Scholar

4 World Anti-Doping Agency. The 2004 Prohibited List. International Standard World Anti-Doping Code (update 25 November 2003). Search in Google Scholar

5 Saugy M, Cardis C, Rivier L, Brisson G, Ayotte C, Hemmersbach P, et al. Urinary human growth hormone (U-hGH): II. Measurements in competition test: more the expression of the renal function than the endocrinological status. In: Donike M, Geyer H, Gotzman A, Mareck-Engelke U, editors. Recent advances in doping analysis (2). Proceedings of the 12th Cologne Workshop on Dope Analysis. Hansen, Köln: Sport and Buch Strauß – Edition Sport, 1995:223–33. Search in Google Scholar

6 Saugy M, Cardis C, Rivier L. Urinary human growth hormone (U-hGH): I. Measurements in non-athletes volunteers after intra-muscular or subcutaneous hGH injections. In: Donike M, Geyer H, Gotzman A, Mareck-Engelke U, editors. Recent advances in doping analysis (2). Proceedings of the 12th Cologne Workshop on Dope Analysis. Hansen, Köln: Sport and Buch Strauß – Edition Sport, 1995:213–22. Search in Google Scholar

7 Cuneo R, Wallace J, Sonksen P. Growth hormone abuse in elite athletes. In: Karch S, editor. Drug abuse handbook. Boca Raton, Florida: CRC Press, 1998:690–710. Search in Google Scholar

8 Breier B, Gallaher B, Gluckman P. Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J Endocrinol 1991; 128: 347–57. 10.1677/joe.0.1280347Search in Google Scholar PubMed

9 Saggese G, Baroncelli GI, Federico G, Bertelloni S. Effects of growth hormone on phosphocalcium homeostasis and bone metabolism. Horm Res 1995; 44(Suppl 3): 55–63. 10.1159/000184675Search in Google Scholar PubMed

10 Niemela O. Collagen breakdown products as markers of fibrosis and cirrhosis. Alcohol Alcohol Suppl 1994; 2: 345–52. Search in Google Scholar

11 Nguyen UN, Mougin F, Simon-Rigaud ML, Rouillon JD, Marguet P, Regnard J. Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes. Eur J Appl Physiol 1998; 78: 533–7. 10.1007/s004210050456Search in Google Scholar PubMed

12 Eliakim A, Brasel JA, Brastow TJ, Mohan S, Cooper DM. Peak oxygen uptake, muscle volume, and the growth hormone-insulin-like growth factor-I axis in adolescent males. Med Sci Sports Exerc 1998; 30: 512–7. 10.1097/00005768-199804000-00007Search in Google Scholar PubMed

13 Eliakim A, Brasel JA, Mohan S, Wong WLT, Cooper DM. Increased physical activity and the growth hormone–IGF-I axis in adolescent males. Am J Physiol 1998; 275: R308–14. 10.1152/ajpregu.1998.275.1.R308Search in Google Scholar PubMed

14 Snow CM, Rosen CJ, Robinson TL. Serum IGF-I is higher in gymnasts than runners and predicts bone and lean mass. Med Sci Sports Exerc 2000; 32; 1902–7. 10.1097/00005768-200011000-00013Search in Google Scholar PubMed

15 Marx JO, Ratamess NA, Nindl BC, Gotshalk LA, Volek JS, Dohi K, et al. Low-volume circuit versus high-volume periodized resistance training in women. Med Sci Sports Exerc 2001; 33: 635–43. 10.1097/00005768-200104000-00019Search in Google Scholar PubMed

16 Borst SE, De Hoyos DV, Garzarella L, Vincent K, Pollock BH, Lowenthal DT, et al. Effects of resistance training on insulin-like growth factor-I and IGF binding proteins. Med Sci Sports Exerc 2001; 33: 648–53. 10.1097/00005768-200104000-00021Search in Google Scholar PubMed

17 Dall R, Lance KHW, Kjaer M, Jorgensen JOL, Christiansen JS, Orskov H, et al. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. J Clin Endocrinol Metab 2001; 86: 669–74. 10.1210/jc.86.2.669Search in Google Scholar

18 Ehrnborg C, Lange KH, Christiansen JS, Lundberg P-A, Baxter RC, Boroujerdi MA, et al. The growth hormone/insulin-like factor-I axis hormones and bone markers in elite athletes in response to maximum exercise test. J Clin Endocrinol Metab 2003; 88: 394–401. 10.1210/jc.2002-020037Search in Google Scholar PubMed

19 Manetta J, Brun JF, Fedou C, Maïmoun L, Prefaut C, Mercier J. Serum levels of insulin-like factor-I (IGF-I), and IGF-binding proteins-1 and -3 in middle aged and young athletes versus sedentary men: relationship with glucose disposal. Metabolism 2003; 52: 821–6. 10.1016/S0026-0495(03)00096-9Search in Google Scholar

20 Takala TE, Vuori J, Anttinen H, Väänänen K, Myllylä R. Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum. Pflügers Arch 1986; 407: 500–3. 10.1007/BF00657507Search in Google Scholar

21 Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715–8. 10.1093/clinchem/34.4.715Search in Google Scholar

22 Takala TE, Vuori JJ, Rahkila PJ, Hakala EO, Karpakka JA, Alen EO, et al. Carbonic anhydrase III and collagen markers in serum following cross-country skiing. Med Sci Sports Exerc 1989; 21: 593–7. 10.1249/00005768-198910000-00016Search in Google Scholar

23 Virtanen P, Viitasalo JT, Vuori J, Väänänen K, Takala TE. Effect of concentric exercise on serum muscle and collagen markers. J Appl Physiol 1993; 75: 1272–7. 10.1152/jappl.1993.75.3.1272Search in Google Scholar

24 Chestnut RE, Quarmby V. Evaluation of total IGF-I assay methods using samples from type I and type II diabetic patients. J Immunol Methods 2002; 259: 11–24. 10.1016/S0022-1759(01)00478-1Search in Google Scholar

25 Fleiss JL. The design and analysis of clinical experiments. New York: Wiley, 1986. Search in Google Scholar

26 Passing H, Bablok W. A new biomedical method procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983; 21: 709–20. Search in Google Scholar

27 Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician 1983; 32: 307–17. 10.2307/2987937Search in Google Scholar

28 Waters DL, Qualls CR, Dorin R, Veldhuis JD, Baumgartner RN. Increased pulsatility, process irregularity and nocturnal trough concentrations of growth hormone in amenorrheic compared to eumenorrheic athletes. J Clin Endocrinol Metab 2001; 86: 1013–9. 10.1210/jc.86.3.1013Search in Google Scholar

29 Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994; 4(Suppl 1): 11–9. Search in Google Scholar